Meanwhile, nanoparticles encoding mRNA for interferon regulatory factor 5 (IRF5) significantly reduced tumor progression in ovarian cancer, melanoma lung metastasis, or glioblastoma models. This evidence concerns the gene IRF5 and glioblastoma.